166 related articles for article (PubMed ID: 30809279)
1. Chemotherapy priming of the Pancreatic Tumor Microenvironment Promotes Delivery and Anti-Metastasis Efficacy of Intravenous Low-Molecular-Weight Heparin-Coated Lipid-siRNA Complex.
Yu Q; Qiu Y; Chen X; Wang X; Mei L; Wu H; Liu K; Liu Y; Li M; Zhang Z; He Q
Theranostics; 2019; 9(2):355-368. PubMed ID: 30809279
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
3. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.
Xia C; Yin S; Xu S; Ran G; Deng M; Mei L; Tang X; Rao J; Li M; Zhang Z; He Q
Theranostics; 2019; 9(2):337-354. PubMed ID: 30809278
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
[TBL] [Abstract][Full Text] [Related]
5. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.
Yin F; Yang C; Wang Q; Zeng S; Hu R; Lin G; Tian J; Hu S; Lan RF; Yoon HS; Lu F; Wang K; Yong KT
Theranostics; 2015; 5(8):818-33. PubMed ID: 26000055
[TBL] [Abstract][Full Text] [Related]
6. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
[TBL] [Abstract][Full Text] [Related]
7. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
[TBL] [Abstract][Full Text] [Related]
8. Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression.
Lu Z; Long Y; Wang Y; Wang X; Xia C; Li M; Zhang Z; He Q
Eur J Pharm Biopharm; 2021 Aug; 165():164-173. PubMed ID: 34020022
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
[TBL] [Abstract][Full Text] [Related]
10. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
[TBL] [Abstract][Full Text] [Related]
11. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
[TBL] [Abstract][Full Text] [Related]
12. MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma.
Rossignoli F; Spano C; Grisendi G; Foppiani EM; Golinelli G; Mastrolia I; Bestagno M; Candini O; Petrachi T; Recchia A; Miselli F; Rovesti G; Orsi G; Veronesi E; Medici G; Petocchi B; Pinelli M; Horwitz EM; Conte P; Dominici M
Theranostics; 2019; 9(2):436-448. PubMed ID: 30809285
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
14. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
15. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
16. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.
Zhu WJ; Yang SD; Qu CX; Zhu QL; Chen WL; Li F; Yuan ZQ; Liu Y; You BG; Zhang XN
Int J Nanomedicine; 2017; 12():3375-3393. PubMed ID: 28490877
[TBL] [Abstract][Full Text] [Related]
18. Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle.
Yang Y; Meng Y; Ye J; Xia X; Wang H; Li L; Dong W; Jin D; Liu Y
J Control Release; 2018 Oct; 287():103-120. PubMed ID: 30144476
[TBL] [Abstract][Full Text] [Related]
19. Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.
Park J; Park J; Castanares MA; Collins DS; Yeo Y
Mol Pharm; 2019 May; 16(5):1864-1873. PubMed ID: 30916974
[TBL] [Abstract][Full Text] [Related]
20. Tumor environment differentiated "nanodepot" programmed for site-specific drug shuttling and combinative therapy on metastatic cancer.
Dong Q; Zhang H; Han Y; Djamila A; Cheng H; Tang Z; Zhou J; Ding Y
J Control Release; 2018 Aug; 283():59-75. PubMed ID: 29803613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
